Etiology, Epidemiology and Prognostics of Acute Kidney Injury (AKI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00953992|
Recruitment Status : Recruiting
First Posted : August 6, 2009
Last Update Posted : August 31, 2017
- To investigate the etiology, epidemiology and prognostic factors of acute kidney injury.
- To find out risk factors that relate with the prognosis of acute kidney injury,focusing on inflammation, oxidative stress and nutritional status.
- To study on the relationship between gene polymorphism and prognosis of acute kidney injury.
|Condition or disease|
|Renal Failure Nutrition Disorders|
to investigate the relationship between preexisting malnutrition and adverse outcomes in patients with AKI
- Several nutritional assessment methods such as anthropometric, clinical and biochemical evaluations have been used; however, no single indicator is considered to be a "gold standard."
- to evaluate the association of serum nutritional variables and prognosis of acute kidney injury
- Given the different half-lives of serum nutritional markers, we hypothesized that the utility of serum nutritional variables as prognostic predictors may differ in early death (<7 days) and late death (>7 days, <28 days) patients.
|Study Type :||Observational|
|Estimated Enrollment :||600 participants|
|Official Title:||The Study of Etiology, Epidemiology and Prognostic Factors of Acute Kidney Injury|
|Study Start Date :||April 2009|
|Estimated Primary Completion Date :||December 2017|
|Estimated Study Completion Date :||December 2018|
- renal function survival rate days in the hospital days in the ICU [ Time Frame: discharg from hospital, 28days,90days ]
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00953992
|Contact: Feng Ding, firstname.lastname@example.org|
|Shanghai Ninth People's Hospital||Recruiting|
|Shanghai, China, 200011|
|Contact: Feng Ding, professor 86-02152888135 email@example.com|
|Principal Investigator:||Feng Ding, professor||Huashan Hospital|